Life sciences briefing: Wednesday, Oct. 17, 2007
Featured companies: Algorithme Pharma, Bacchus Vascular, Botaneco, Cubist Pharmaceuticals, Ikonisys, Healthcare Management Systems, Illumigen Biosciences, Kilmer Capital Partners, Medical Specialties Distributors, Metastatix, Microphage, Orthosoft, Thomas McNerney & Partners, TranS1, TriReme Medical, Wren Medical, Zimmer
UPDATE: Expanded TriReme Medical, Ikonisys and TranS1 items.
UPDATE REDUX: Added MicroPhage item.
Stent-maker TriReme Medical sails off with $15.6M — Pleasanton, Calif.-based TriReme Medical, a device maker developing a new type of artery-opening stent for blood-vessel junctions, raised $15.6 million in a third funding… Continue Reading
Life sciences briefing: Thursday, Sept. 13, 2007
Featured companies: Aldagen, LDR, Lyten Endoscopy, MachLabs, Permatox, TeleMedicine Clinic, ThromboVision
Spinal-implant maker LDR raises $25M — Austin, Texas-based LDR, a maker of spinal implants, raised $25 million in a third funding round. Investors included Telegraph Hill Partners, Austin Ventures, Rothschild Private Equity and PTV Sciences.
LDR sells spinal-fusion devices, artificial disks and other spine-related devices in more than 30 countries, and plans to use the funds for further expansion.
Aldagen adds $9M for adult stem-cell work — Aldagen,… Continue Reading
Life sciences briefing: Tuesday, Sept. 11, 2007
Featured companies: Enobia, F-star, N Spine, Omni Life Science
Enobia splints together $38M for bone disorders — Montreal’s Enobia, a biotech focused on aiming drugs specifically at bone diseases, raised C$40.1 million ($38 million) in a second funding round. Investors included OrbiMed Advisors, CTI Life Sciences Fund, the Fonds de solidarite FTQ, Desjardins Venture Capital, Lothian Partners and T2C2/Bio 2000.
Enobia intends to deliver bone-related drugs directly to bone tissue in order to reduce both dosages and possible… Continue Reading
Ouroboros raises $1.2M for spinal devices
OuroBoros, a San Diego developer of devices for minimally invasive spinal fusion, raised $1.17 million in a planned $4 million first funding round, PE Wire reports, citing a regulatory filing. The deal was led by Ascent Medical Ventures.
Orthopedic Development pulls in $8M for spinal-fusion devices
Orthopedic Development, a Clearwater, Fla., maker of spinal-fusion devices, raised $8 million in an oversubscribed institutional funding round. The private placement, handled by GunnAllen Financial, was entirely funded by individual investors, VentureWire reports (subscription required).
Orthopedic Development’s operating subsidiary, MinSurg, makes and sells a fusion device called TruFuse, which involves the use of small pieces of human bone, rather than plates and screws, to stabilize the spine. The proceeds of the round will be used to… Continue Reading